Efficacy of Direct Acting Oral Anticoagulants in Treatment of Left Ventricular Thrombus
Authors:
- 1 August 2019
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (3) , 367-372
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients With Atrial FibrillationThe American Journal of Cardiology, 2019
- Use of direct oral anticoagulants in the treatment of left ventricular thrombi: A tertiary center experience and review of the literatureClinical Case Reports, 2018
- Left Ventricular Thrombus After Acute Myocardial InfarctionJAMA Cardiology, 2018
- Anticoagulation combined with antiplatelet therapy in patients with left ventricular thrombus after first acute myocardial infarctionEuropean Heart Journal, 2017
- Oral factor Xa inhibitors for the treatment of left ventricular thrombus: a case seriesJournal of Thrombosis and Thrombolysis, 2017
- Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic AttackStroke, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Apixaban versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2011
- Rivaroxaban versus Warfarin in Nonvalvular Atrial FibrillationNew England Journal of Medicine, 2011
- Dabigatran versus Warfarin in Patients with Atrial FibrillationNew England Journal of Medicine, 2009